<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Daily Stocks News &#187; CLDX</title>
	<atom:link href="http://news.dailystocks.com/tag/cldx/feed/" rel="self" type="application/rss+xml" />
	<link>http://news.dailystocks.com</link>
	<description>Stocks with Insider Buying, Stock Search Engine, Glossary, Education, Reviews</description>
	<lastBuildDate>Mon, 21 Jan 2019 17:42:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Major Movers on July 5; CLDX, ARR, FBP, MDC</title>
		<link>http://news.dailystocks.com/3327/major-movers-on-july-5-cldx-arr-fbp-mdc/</link>
		<comments>http://news.dailystocks.com/3327/major-movers-on-july-5-cldx-arr-fbp-mdc/#comments</comments>
		<pubDate>Sat, 06 Jul 2013 13:47:49 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[ARR]]></category>
		<category><![CDATA[CLDX]]></category>
		<category><![CDATA[FBP]]></category>
		<category><![CDATA[MDC]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=3327</guid>
		<description><![CDATA[<p>Shares of Celldex Therapeutics Inc. (NASDAQ: CLDX), a biopharmaceutical company engaged in the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases, surged in trading on Friday.</p> <p></p> <p>CLDX shares ended the day 14.05% higher at $21.27 on above average volume of 6.48 million. The stock hit a [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/3327/major-movers-on-july-5-cldx-arr-fbp-mdc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Major Movers on July 2; CLNT, ACHN, SHLM, ZNGA, CLDX</title>
		<link>http://news.dailystocks.com/3311/major-movers-on-july-2-clnt-achn-shlm-znga-cldx/</link>
		<comments>http://news.dailystocks.com/3311/major-movers-on-july-2-clnt-achn-shlm-znga-cldx/#comments</comments>
		<pubDate>Tue, 02 Jul 2013 15:42:58 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[ACHN]]></category>
		<category><![CDATA[CLDX]]></category>
		<category><![CDATA[CLNT]]></category>
		<category><![CDATA[SHLM]]></category>
		<category><![CDATA[ZNGA]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=3311</guid>
		<description><![CDATA[<p>Shares of Cleantech Solutions Inc. (NASDAQ: CLNT) skyrocketed 26% in early trade. The Company provided upbeat guidance for the fiscal 2013. Based on current orders and anticipated orders, Cleantech expects net income to be in the range of $8 million to $8.5 million on revenue range of $60 million to $62 million.</p> <p></p> <p>“We expect [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/3311/major-movers-on-july-2-clnt-achn-shlm-znga-cldx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Major Movers on December 10; ZGNX, CLDX, CBMX, MCD, HPQ, AAPL</title>
		<link>http://news.dailystocks.com/2003/major-movers-on-december-10-zgnx-cldx-cbmx-mcd-hpq-aapl/</link>
		<comments>http://news.dailystocks.com/2003/major-movers-on-december-10-zgnx-cldx-cbmx-mcd-hpq-aapl/#comments</comments>
		<pubDate>Mon, 10 Dec 2012 19:01:20 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[CBMX]]></category>
		<category><![CDATA[CLDX]]></category>
		<category><![CDATA[HPQ]]></category>
		<category><![CDATA[MCD]]></category>
		<category><![CDATA[ZGNX]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=2003</guid>
		<description><![CDATA[<p>Shares of Zogenix Inc. (NASDAQ: ZGNX), a pharmaceutical company which focuses on treatment related to central nervous disorder and pain, plummeted 46 percent on Monday after the Company revealed that Food and Drug Administration’s advisory committee voted against the application for approval of a pain treatment.</p> <p></p> <p>Just about a month ago, Zogenix reported lighter-than-expected [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/2003/major-movers-on-december-10-zgnx-cldx-cbmx-mcd-hpq-aapl/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
